Interestingly, although BRAF inhibitor‐resistant melanoma cells were shown to depend on YAP/TAZ for their proliferation and survival,178 YAP/TAZ activity is not associated with the mutation status of BRAF and NRAS.176. This evidence concerns the gene YAP1 and melanoma.